$NEOV
NeoVolta Inc. Stock $neov

$neov Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000168316824007816 Filed on November 08, 2024

Income Statement

Concept	2024 Q4	2024 Q3
Revenue		$590.2K
YoY Change		-22.76%
Cost Of Revenue		$497.4K
YoY Change		-22.64%
Gross Profit		$92.85K
YoY Change		-23.38%
Gross Profit Margin		15.73%
Selling, General & Admin		$1.050M
YoY Change		87.52%
% of Gross Profit		1131.02%
Research & Development		$8.617K
YoY Change
% of Gross Profit		9.28%
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses		$1.059M
YoY Change		90.71%
Operating Profit		-$965.9K
YoY Change		122.56%
Interest Expense		$1.400K
YoY Change
% of Operating Profit
Other Income/Expense, Net		$1.395K
YoY Change		-73.54%
Pretax Income		-$964.5K
YoY Change		124.3%
Income Tax
% Of Pretax Income
Net Earnings		-$964.5K
YoY Change		124.97%
Net Earnings / Revenue		-163.41%
Basic Earnings Per Share		-$0.03
Diluted Earnings Per Share		-$0.03
COMMON SHARES
Basic Shares Outstanding	33.36M shares	33.25M shares
Diluted Shares Outstanding		33.24M shares

Balance Sheet

Concept	2024 Q4	2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments		$393.4K
YoY Change		-78.38%
Cash & Equivalents		$393.4K
Short-Term Investments
Other Short-Term Assets		$38.41K
YoY Change		-23.18%
Inventory		$1.768M
Prepaid Expenses
Receivables		$1.951M
Other Receivables		$0.00
Total Short-Term Assets		$4.150M
YoY Change		-32.76%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets		$0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets		$4.150M
Total Long-Term Assets		$0.00
Total Assets		$4.150M
YoY Change		-32.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$216.3K
YoY Change
Accrued Expenses		$37.44K
YoY Change		-25.12%
Deferred Revenue
YoY Change
Short-Term Debt		$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities		$253.8K
YoY Change		413.95%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities		$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities		$253.8K
Total Long-Term Liabilities		$0.00
Total Liabilities		$253.8K
YoY Change		407.56%
SHAREHOLDERS EQUITY
Retained Earnings		-$21.71M
YoY Change		15.05%
Common Stock		$33.25K
YoY Change		0.27%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity		$3.896M
YoY Change
Total Liabilities & Shareholders Equity		$4.150M
YoY Change		-32.76%

Cashflow Statement

Concept	2024 Q4	2024 Q3
OPERATING ACTIVITIES
Net Income		-$964.5K
YoY Change		124.97%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities		-$593.0K
YoY Change		231.14%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities		-$593.0K
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash		-$593.0K
YoY Change		231.14%
FREE CASH FLOW
Cash From Operating Activities		-$593.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q3	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2024Q3	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q3	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
CY2024Q3	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	5316	usd
CY2024Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	37442	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	55784	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	253775	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	61100	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	33246	usd
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	33236	usd
CY2024Q3	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2025
CY2024Q3	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q3	dei	Entity Central Index Key EntityCentralIndexKey	0001748137
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q3	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023Q3	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2024Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2024Q3	dei	Document Type DocumentType	10-Q
CY2024Q3	dei	Entity File Number EntityFileNumber	001-41447
CY2024Q3	dei	Entity Registrant Name EntityRegistrantName	NeoVolta, Inc.
CY2024Q3	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2024Q3	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	82-5299263
CY2024Q3	dei	Entity Address Address Line1 EntityAddressAddressLine1	13651 Danielson Street
CY2024Q3	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite A
CY2024Q3	dei	Entity Address City Or Town EntityAddressCityOrTown	Poway
CY2024Q3	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2024Q3	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92064
CY2024Q3	dei	City Area Code CityAreaCode	(800)
CY2024Q3	dei	Local Phone Number LocalPhoneNumber	364-5464
CY2024Q3	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q3	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q3	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q3	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q3	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024Q3	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2024Q3	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	33361711	shares
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	393396	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	986427	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1950684	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1805980	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	1767624	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	1787308	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	38406	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	76815	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	4150110	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	4656530	usd
CY2024Q3	us-gaap	Assets Assets	4150110	usd
CY2024Q2	us-gaap	Assets Assets	4656530	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	216333	usd
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33245867	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33245867	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33236091	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33236091	shares
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	25570121	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	25304732	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-21707032	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-20742538	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	3896335	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	4595430	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4150110	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4656530	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	590236	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	764130	usd
CY2024Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	497389	usd
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	642958	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	92847	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	121172	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1050119	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	555160	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8617	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	0	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	1058736	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	555160	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-965889	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-433988	usd
CY2024Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	1395	usd
CY2023Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	5273	usd
CY2024Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1395	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	5273	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-964494	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-428715	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33244061	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33244061	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33155127	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33155127	shares
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	4595430	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	265399	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-964494	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	3896335	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	6466373	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	84717	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-428715	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	6122375	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-964494	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-428715	usd
CY2024Q3	us-gaap	Share Based Compensation ShareBasedCompensation	265399	usd
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	84717	usd
CY2024Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	85250	usd
CY2023Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	110000	usd
CY2024Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	229954	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	359129	usd
CY2024Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-19684	usd
CY2023Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-353349	usd
CY2024Q3	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-38409	usd
CY2023Q3	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-50803	usd
CY2024Q3	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	211017	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	0	usd
CY2024Q3	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-18342	usd
CY2023Q3	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	9886	usd
CY2024Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-593031	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-179089	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-593031	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-179089	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	986427	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2002789	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	393396	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1823700	usd
CY2024Q3	us-gaap	Cash Uninsured Amount CashUninsuredAmount	143396	usd
CY2023Q2	us-gaap	Inventory Gross InventoryGross	1400000	usd
CY2024Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	90000	usd
CY2024Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	90000	usd
CY2024Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	1339559	usd
CY2024Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	1076479	usd
CY2024Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	0	usd
CY2024Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	89386	usd
CY2024Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	428065	usd
CY2024Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	621443	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	1767624	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	1787308	usd
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1020000	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1030000	usd
CY2024Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2693775	shares
CY2024Q3	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_849_eus-gaap--UseOfEstimates_zDNsru8vHBx3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_86B_zTy5twqYMe61">Use of Estimates</span></i> – Management has made a number of estimates and assumptions in preparing these financial statements in conformity with accounting principles generally accepted in the United States of America. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p>
CY2024Q3	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	5000000	usd
CY2024Q3	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.16	pure
CY2024Q3	us-gaap	Line Of Credit Facility Expiration Date1 LineOfCreditFacilityExpirationDate1	2026-09-03
CY2024Q3	us-gaap	Line Of Credit LineOfCredit	0	usd
CY2024Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1179750	shares
CY2024Q3	us-gaap	Warrants And Rights Outstanding Maturity Date WarrantsAndRightsOutstandingMaturityDate	2027-08-01
CY2024Q3	us-gaap	Other Noncash Expense OtherNoncashExpense	265399	usd
CY2023Q3	us-gaap	Other Noncash Expense OtherNoncashExpense	84717	usd
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001683168-24-007816-index-headers.html	Edgar Link	pending
0001683168-24-007816-index.html	Edgar Link	pending
0001683168-24-007816.txt	Edgar Link	pending
0001683168-24-007816-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
neov-20240930.xsd	Edgar Link	pending
neovolta_ex3101.htm	Edgar Link	pending
neovolta_ex3102.htm	Edgar Link	pending
neovolta_ex3201.htm	Edgar Link	pending
neovolta_ex3202.htm	Edgar Link	pending
neovolta_i10q-93024.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
neov-20240930_cal.xml	Edgar Link	unprocessable
neov-20240930_def.xml	Edgar Link	unprocessable
neov-20240930_lab.xml	Edgar Link	unprocessable
neov-20240930_pre.xml	Edgar Link	unprocessable
neovolta_i10q-93024_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NEOV
NeoVolta Inc. Stock $neov

2024 Q4 Form 10-Q Financial Statement

#000168316824007816 Filed on November 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NEOV NeoVolta Inc. Stock $neov

2024 Q4 Form 10-Q Financial Statement

#000168316824007816 Filed on November 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NEOV
NeoVolta Inc. Stock $neov